16_potopnyk

Ser. Khim. 2008. No 49. Part 2. P. 96–101 O (&)
Ph-NH-NH2
1) KOH, EtOH
8, X = S, Y = O;
9, X = O, Y = S
10, X = S, Y = O;
11, X = O, Y = S
10, 11 13,
18–21. +
R = COOEt (14,18); C(S)NH2 (15,19); CONHPh (16,20);
! 2-(* !+,( $
5+4 1H, ': 1,33 (3 H, CH3,.2, J = 6,8); 2,06 (3 ., CH3); 4,20 (2 ., ,.2), J = 6,8); 6,84 (1 H, Ph); 7,19–7,28 (4 H, Ph); 9,65 (1 H, , %: C 63,77; H 6,32; N 13,12. C11H14N2O2. ) ! 4-* (% !-1-* !-1H- ( $ !-3-
5+4 1H, ': 1,42 (3 H, CH3,.2, J = 7,2); 4,42 (2 H, CH2), J = 7,2); 7,40 (1 H, Ph, J = 7,6); 7,51 (2 H, Ph, J = 7,6); 7,98 (2 H, Ph, J = 7,6); 9,17 , %: C 63,27; H 4,84; N 11,02. C13H12N2O3. (% !-1-* !-1H- ( $ !-3-
5+4 1., ': 7,41 (1 ., Ph, J = 8,0); 7,53 (2 ., Ph, J = 8,0); 8,00 (2 ., Ph, J = 8,0); 9,14 (1 ., $ ! 4-[(1,3-R2-2,4,6- (
" ( +,( -5(2H)-
% !]-1-* !-1 - ( $ !-3-
& (6, 7).
4-[(2,4,6- (
" ( +,( -5(2H)-
! , )% !]-1-* !-
1 - ( $!-3- (# " ! (6).
(2 H, CH2)); 7,48 (1 H, Ph); 7,60 (2 H, Ph); 7,85 (2 H, Ph); 8,96 (1 H, 9,67 (1 H, CH=); 11,31 (1 ., NH); 11,37 (1 ., NH). ! ! 4-[(1,3-, % !-2,4,6- (
" ( +,( -5(2H)-
!]-1-* !-1 - ( $ !-3-
(2), 0,32 (2,0
5+4 1H, ': 1,41 (3 H, CH3,.2); 3,12 (6 ., 2CH3N); 4,41 (2 H, CH2)); 7,49 (1 H, Ph); 7,60 (2 H, Ph); 7,83 (2 H, Ph); 9,01 (1 H, , %: C 58,91; H 4,55; N 14,32. C19H18N4O5. ) 4-[(4(2)- " -2(4)-
" -1,3-
$ ! , -5- ! , )% !]-1-* !-1 -
(10, 11). ,
4-[(4- " -2-
" -1,3-
$ ! , -5- ! , )% !]-1-* !-1 - ( -
(10). * . = 235 °,.
4-[(2- " -4-
" -1,3-
$ ! , -5- ! , )% !]-1-* !-1 - ( -
(11). * . = 238 °,.
CH3,.2); 4,34 (2 H, CH2)); 7,41 (1 H, Ph); 7,52 (2 H, Ph); 7,92 (2 H, Ph); 8,01 ! 4-[(3-% !-5-
" -1-* !-1,5-, +,( -4 - ( $ !-4- ! , )% !]-1-
* !-1 - ( $ !-3-
(2), 0,7 (4,1
, %: C 68,17; H 4,82; N 13,55. C23H20N4O3. ) 18–21.
1417 8
-3- " -3- " -1- ( !)-1-* !-1 - ( $!-3- (# -
(18). * . = 126128 °, (
CH3,.2); 1,43 (3 H, CH3,.2); 4,34 (2 H, CH2)); 4,41 (2 H, CH2)); 7,47 (1 H, Ph); 7,58 (2 H, Ph); 7,89 (2 H, Ph); 8,86 (1 H, CH=); 9,14 (1 H, -3- " -1- ( !)-1-* !-1 - ( $!-3- (# -
(19). * . = 188190 °, (
1,43 (3 H, CH3,.2, J = 7,2); 4,43 (2 H, CH2), J = 7,2); 7,11 (1 H, Ph, J = 7,6); 7,33 (2 H, Ph, J = 7,6); 7,47 (1 H, Ph, J = 7,6); 7,60 (2 H, Ph, J = 7,6); 7,70 (2 H, Ph, J = 7,6); 7,92 (2 H, Ph, J = 7,6); 8,75 (1 H, CH=); 9,15 (1 H, , %: C 67,21; H 4,63; N 14,05. C22H18N4O3. ) 4-(3- % -2--
" -1- ( !)-1-* !-1 - ( $ !-3-
(20). * . = 264265 °, ( +60).
(3 H, CH3,.2, J = 7,2); 4,41 (2 H, CH2), J = 7,2); 7,46 (1 H, Ph, J = 7,6); 7,59 (2 H, Ph, J = 7,6); 7,89 (2 H, Ph, J = 7,6); 8,70 (1 H, CH=); 9,16 (1 H, -2-(4-* !-1,3- $!-2- !) !]-1-* !-1 - ( $!-3- (-
(21). * . = 196 °, ( +60).
CH3,.2, J = 7,2); 4,45 (2 H, CH2), J = 7,2); 7,36 (1 ., Ph); 7,45 (3 ., Ph); 7,60 (2 ., Ph); 7,93 (2 ., Ph); 8,01 (2 ., Ph); 8,12 (1 ., , %: C 66,84; H 4,03; N 12,86, S 7,42. C24H18N4O2S. ) $ 2-* !-2,6-, +,( -7H- ( $ ! [3,4-d]
2, 18–21 7
5+4 1.: 7,47 (1 ., Ph, J = 7,6); 7,58 (2 H, Ph, J = 7,6); 8,03 (2 ., Ph, J = 7,6); 8,26 c 1. Bebernitz G.R., Argentieri G., Battle B., Brennan C., Balkan B., Burkey B.F. et al. The Effect of 1.3-Diaryl-[1H]-pyrazole-4-acetamides on Glucose Utilization in ob/ob Mice // J. Med. Chem. 2001. Vol. 44. N 16. P. 2601–2611. 2. Abadi A.H., Eissa A.A.H., Hassan G.S. Synthesis of novel 1,3,4-trisubstituted pyrazole derivatives and their evaluation as antitumor and antiangiogenic agents // Chem. Pharm. 3. Lange J.H.M., van Stuivenberg H.H., Coolen H.K.A.C., Adolfs T.J.P. et al. Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists // J. Med. Chem. 2005. Vol. 48. N 6. 4. Mallegol T., Gmouh S., Meziane M.A.A., Blanchard-Desce M., Mongin O. Practical and Efficient Synthesis of Tris(4-formylphenyl)amine, a Key Building Block in Materials Chemistry // Synthesis. 2005. N 11. 4. 1771–1774. 5. Caluwe P. Heteroannelations with o-aminoaldehydes // Tetrahedron. 1980. Vol. 36. 6. Denison S., Hilton S.T. A Convenient Synthesis of 2-Cyano-3-Substituted Indoles // Synlett. 2004. N 15. P 2806–2808.07.12.204 7. Kira M.A., Abdel-Raemann M.O., Gadalla K.Z. The VilsmeierHaack reaction.
III. Cyclization of hydrazones to hyrazoles // Tetrahedron Lett. 1969. N 2. P. 109–110. 8. Kira M.A., Aboul-Enein N.M., Korkor K.Z. The VilsmeierHaack reaction. IV. Reaction
of Phosphorus Oxychloride-Dimethylformamide with Semicarbazones // J. Heterocycl. 9. Brehme R., Gründemann E., Schneider M. Reaktion von Acetophenonmono-methyl- und -dimethylhydrazonen mit dem VilsmeierReagenz; Bildung von Pyrazol-4-
carbiminiumsalzen: ein Beitrag zum Mechanismus // J. Prakt. Chem. 2000. Bd. 7. SYNTHESIS AND CHEMICALS CHARACTERISTICS OF ETHYL
4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLATE
M. Potopnyk, V. Matiychuk
Ivan Franko National University of Lviv, Kyryla & Mefodiya Str., 6, 79005 Lviv, Ukraine Ethyl 4-formyl-1-phenyl-1H-pyrazole-3-carboxylate was synthesized by reaction of ethyl 2-(phenylhydrazono)propanoate with the Vilsmeier–Haack complex. New methods of synthesis of 2-phenil-2,6-dihydro-7H-pyrazolo[3,4-d]pyridazin-7-one were suggested. Key words: pyrazoles, Vilsmeier–Haack reagent.

Source: http://chem.lnu.edu.ua/visnyk_2008/ORGAN/16_Potopnyk.pdf

Layout

IMPORTANT INFORMATION ABOUT TAKING YOUR TRANSPLANT DRUGS After an organ transplant you need to take medication such as ciclosporin or tacrolimus to help prevent you from rejecting that organ. How you take your medication is very important. Below are some key things to remember. For further details or if you have any questions, ask your transplant nurse, doctor or phar

opensourceintelligence.eu

overview of significant cyber warfare events from the newsThis is Cyberthings for Managers, created on Sunday 5th August, 2012, at 10:20 o’clock (GMT+1), reporting onsignificant developments in the world of Cyber warfare, intended for managers. Subscription information in the back. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Copyright © 2010 Health Drug Pdf